Dr. Vickers on quantifying Gleason pattern 4 in prostate cancer
March 30th 2024“I would just say that urologists should be focusing much more on the total amount of pattern 4, if they have that information available, than on the ratio of pattern 3 and 4, and therefore the grade group,” says Andrew J. Vickers, PhD.
Dr. Sutherland discusses what's on the horizon in tibial nerve stimulation
March 26th 2024“I think the long and short of it is we know tibial nerve stimulation works, we're just trying to identify what's the best way by which we can deliver it conveniently and cost effectively to the patient,” says Suzette E. Sutherland, MD, MS, FPMRS.
Dr. Schaeffer looks ahead on what to expect from PSMA-PET in prostate cancer
March 21st 2024"PSMA-PET is a radio nucleotide-based imaging modality that really has changed the landscape of how we initially stage and subsequently follow individuals who have a diagnosis of prostate cancer," says Edward M. Schaeffer, MD, PhD.
Dr. Zorn on new technologies to optimize care for BPH
March 18th 2024“These are the technologies that we'll see to empower patients and get more information, so that when we see the patient, it's one less thing we as a physician have to gather during that consultation, making the consultation more efficient,” says Kevin C. Zorn, MD, FRCSC, FACS.